Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
13.42
+0.28 (2.13%)
Aug 10, 2026, 3:01 PM EDT - Market open

Alpha Tau Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-42.63-31.75-29.16-33.76-27.27
Depreciation & Amortization
2.051.891.81.510.78
Stock-Based Compensation
10.629.927.936.750.81
Other Adjustments
1.88-0.95-1.11.3113.29
Changes in Accounts Payable
0.340.971.140.220.24
Changes in Accrued Expenses
1.130.661.23-1.212.08
Changes in Other Operating Activities
-0.07-0.520.21.3-1.73
Operating Cash Flow
-26.68-19.78-17.96-23.88-11.81
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-6.08-2.24-6.4-0.9-2.93
Purchases of Investments
-70.49-125.19-166.78-121.14-8.08
Proceeds from Sale of Investments
55.98148.19191.8632.1130.28
Investing Cash Flow
-20.5920.7718.68-89.9419.27

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
5.15----
Short-Term Debt Repaid
-5.15----
Long-Term Debt Issued
--5.25--
Net Long-Term Debt Issued (Repaid)
--5.25--
Issuance of Common Stock
45.770.030.0596.910.11
Net Common Stock Issued (Repurchased)
45.770.030.0596.910.11
Financing Cash Flow
45.770.035.396.910.11

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.020.06-0.05-0.260.11
Net Cash Flow
-1.521.075.97-17.177.68

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-32.76-22.02-24.36-24.78-14.74
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.41-0.31-0.35-0.39-0.36
Levered Free Cash Flow
-45.25-30.99-25.94-32.84-28.84
Unlevered Free Cash Flow
-45.03-35.29-37.73-31.24-15.36
SEC Filings: 10-K · 10-Q